Viridans streptococcal sepsis: Clinical features and complications in childhood acute myeloid leukemia

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 9, 2003, Pages 696-703

  Okamoto, Yasuhiro ^a   Ribeiro, Raul C ^a,b   Srivastava, Deo Kumar ^a   Shenep, Jerry L ^a,b   Pui, Ching Hon ^a,b   Razzouk, Bassem I ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Acute myeloid leukemia; Aspergillosis; Bacteremia; Pediatrics; Streptococcal infection

Indexed keywords

ANTIFUNGAL AGENT; ASPARAGINASE; CLADRIBINE; COTRIMOXAZOLE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYPERTENSIVE FACTOR; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME INVERSION; CHROMOSOME INVERSION 16; CHROMOSOME TRANSLOCATION 8; CHROMOSOME TRANSLOCATION 9; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOGENETICS; FEMALE; HUMAN; HYPOTENSION; INCIDENCE; LUNG ASPERGILLOSIS; MALE; MYCOSIS; OXYGEN THERAPY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; SEPSIS;

ACUTE DISEASE; ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; COMBINED MODALITY THERAPY; CYTARABINE; DAUNORUBICIN; DEOXYADENOSINES; DOUBLE-BLIND METHOD; ETOPOSIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPOTENSION; IMMUNOCOMPROMISED HOST; LEUKEMIA, MYELOID; MALE; MYCOSES; NEUTROPENIA; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; SEPSIS; STREPTOCOCCAL INFECTIONS; VIRIDANS STREPTOCOCCI;

EID: 0043236316     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200309000-00005     Document Type: Article

References (25)

1. th AML trial. MRC Childhood Leukaemia Working Party. Br J Haematol. 1998;101:130-140.
2. Creutzig U, Ritter J, Zimmermann M, et al. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Munster 93. J Clin Oncol. 2001;19:2705-2713.
3. Hann IM, Stevens RF, Goldstone AH, et al. Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the Medical Research Council. Blood. 1997;89:2311-2318.
4. Riley LC, Hann IM, Wheatley K, et al. Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MRC Childhood Leukaemia Working Party. Br J Haematol. 1999;106:436-444.
5. Pizzo PA, Ladisch S, Witebsky FG. Alpha-hemolytic streptococci: clinical significance in the cancer patient. Med Pediatr Oncol. 1978;4:367-370.
6. Weisman SJ, Scoopo FJ, Johnson GM, et al. Septicemia in pediatric oncology patients: the significance of viridans streptococcal infections. J Clin Oncol. 1990;8:453-459.
7. Patrick CC. Viridans streptococcal infections in patients with neutropenia. Pediatr Infect Dis J. 1999;18:280-281.
8. Shenep JL. Viridans-group streptococcal infections in immunocompromised hosts. Int J Antimicrob Agents. 2000;14:129-135.
9. Gamis AS, Howells WB, DeSwarte-Wallace J, et al. Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a report from the Children's Cancer Group Study CCG-2891. J Clin Oncol. 2000;18:1845-1855.
10. Krance RA, Hurwitz CA, Head DR, et al. Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases. J Clin Oncol. 2001;19:2804-2811.
11. Crews KR, Ghandi V, Srivastava DK, et al. An interim comparison of a continuous infusion versus a short daily infusion of cytarabine given with cladribine for pediatric acute myeloid leukemia. J Clin Oncol. 2002;20:4217-4224.
12. Rubnitz JE, Raimondi SC, Tong X, et al. Favorable impact of the t(9:11) in childhood acute myeloid leukemia. J Clin Oncol. 2002;20:2302-2309.
13. Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial. Blood. 1998;92:2322-2333.
14. Raimondi SC, Chang MN, Ravindranath Y, et al. Chromosomal abnormalities in 478 children with acute myeloid leukemia: Clinical characteristics and treatment outcome in a cooperative Pediatric Oncology Group study POG 8821. Blood. 1999;194:3707-3716.
15. Prentice RL, Kalbfleisch JD, Peterson AV Jr, et al. The analysis of failure times in the presence of competing risks. Biometrics. 1978;34:541-544.
16. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-1154.
17. Elting LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis. 1992;14:1201-1207.
18. Dompeling EC, Donnelly JP, Raemaekers JM, et al. Pre-emptive administration of corticosteroids prevents the development of ARDS associated with Streptococcus mitis bacteremia following chemotherapy with high-dose cytarabine. Ann Hematol. 1994;69:69-71.
19. Sotiropoulos SV, Jackson MA, Woods GM, et al. Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside. Pediatr Infect Dis J. 1989;8:755-758.
20. Villablanca JG, Steiner M, Kersey J, et al. The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients. Bone Marrow Transplant. 1990;5:387-393.
21. Kanter MC, Hart RG. Neurologic complications of infective endocarditis. Neurology. 1991;41:1015-1020.
22. Church DL, Bryant HE. Investigation of a Streptococcus viridans pseudobacteremia epidemic at a university teaching hospital. Infect Control Hosp Epidemiol. 1989;10:416-421.
23. Hoecker JL, Pickering LK, Groschel D, et al. Streptococcus salivarius sepsis in children with malignancies. J Pediatr. 1978;92:337-338.
24. Shenep JL, Hughes WT, Roberson PK, et al. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. N Engl J Med. 1988;319:1053-1058.
25. Bruckner LB, Korones DN, Karnauchow T, et al. High incidence of penicillin resistance among alpha-hemolytic streptococci isolated from the blood of children with cancer. J Pediatr. 2002;140:20-26.